Montage Gold (CVE:MAU – Free Report) had its target price hoisted by BMO Capital Markets from C$3.00 to C$3.75 in a research report released on Friday morning, BayStreet.CA reports.
A number of other equities analysts also recently commented on MAU. National Bank Financial upgraded Montage Gold to a “strong-buy” rating in a report on Monday, July 22nd. Stifel Nicolaus dropped their price objective on Montage Gold from C$2.60 to C$2.20 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Cormark increased their price objective on Montage Gold from C$2.00 to C$2.50 in a report on Thursday, August 15th. National Bankshares set a C$2.50 price objective on Montage Gold and gave the stock an “outperform” rating in a report on Tuesday, July 23rd. Finally, Ventum Cap Mkts upgraded Montage Gold to a “strong-buy” rating in a report on Friday, September 27th. Five research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Montage Gold currently has a consensus rating of “Buy” and a consensus price target of C$2.74.
View Our Latest Stock Analysis on MAU
Montage Gold Price Performance
Montage Gold (CVE:MAU – Get Free Report) last released its earnings results on Thursday, August 22nd. The company reported C($0.03) earnings per share for the quarter, missing the consensus estimate of C($0.01) by C($0.02). On average, analysts predict that Montage Gold will post -0.04 EPS for the current year.
Montage Gold Company Profile
Montage Gold Corp., a precious metals exploration and development company, engages in the exploration and development of mineral properties. Its flagship property is the Koné Gold Project covering an area of 2,259 square kilometers located in the Côte d'Ivoire, West Africa. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Further Reading
- Five stocks we like better than Montage Gold
- Roth IRA Calculator: Calculate Your Potential Returns
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Health Care Stocks Explained: Why You Might Want to Invest
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Montage Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Montage Gold and related companies with MarketBeat.com's FREE daily email newsletter.